Comprehensive next generation sequencing services
MedGenome's California headquarters has state-of-the-art Next Generation Sequencing (NGS) platforms for high-throughput sequencing services. Our service offerings include RNA, whole genome, epigenome, whole exome and targeted sequencing. In addition, MedGenome offers single cell sequencing, spatial transcriptomics and antibody discovery services using the 10X Genomics platform. Our services are supported by robust bioinformatics pipelines to generate high quality insights.
Global reach, near you
We serve academic and industry researchers across 35+ countries including South America, the Middle East and Africa.
Advancing precision medicine can reduce healthcare disparities and improve patient outcomes. MedGenome is a founding member of the GenomeAsia 100K, an initiative to sequence 100,000 genomes in Asia, making us a unique resource of genetic research for the world. We deliver benefits to all stakeholders within the global research community with our network of clinicians and hospitals, proprietary tools, and scientific expertise. Our access to untapped genomic data from diverse ethnicities from previously underserved regions such as LATAM, Africa, the Middle East, and Asia enables us to accelerate disease biology research and biomarker discovery.
Leadership and investors
Our Investors
Our customers
careers
MedGenome offers a vibrant research environment utilizing NGS. We provide exciting and challenging opportunities to enhance and expand one's skill sets and the flexibility to work across teams.
News
NEWS
NEWS
Multiomics Services
Sequencing Services
Research & Pharma Solutions
Resources
About
Contact
US
IN
